SecBot SecBot
Biotech Drug Report Generated Nov 16, 2026

EQ302

EQ·Equillium, Inc.
NEUTRAL
Trial phase
Not stated
Time to market
Not stated
⚠ Few sources Few sources were found for this drug. Treat the rating as low-confidence and verify against the cited sources.

Price Chart

Loading chart...

Source Filing

The SecBot filing or press-release report that triggered this drug report:

Equillium, Inc. S-3 EQ ·Originating report